Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals

健康人和免疫功能低下者对SARS-CoV-2 mRNA疫苗的生发中心反应

阅读:3
作者:Katlyn Lederer,Emily Bettini,Kalpana Parvathaneni,Mark M Painter,Divyansh Agarwal,Kendall A Lundgreen,Madison Weirick,Kavitha Muralidharan,Diana Castaño,Rishi R Goel,Xiaoming Xu,Elizabeth M Drapeau,Sigrid Gouma,Jordan T Ort,Moses Awofolaju,Allison R Greenplate,Carole Le Coz,Neil Romberg,Jennifer Trofe-Clark,Gregory Malat,Lisa Jones,Mark Rosen,Daniela Weiskopf,Alessandro Sette,Behdad Besharatian,Mary Kaminiski,Scott E Hensley,Paul Bates,E John Wherry,Ali Naji,Vijay Bhoj,Michela Locci

Abstract

Vaccine-mediated immunity often relies on the generation of protective antibodies and memory B cells, which commonly stem from germinal center (GC) reactions. An in-depth comparison of the GC responses elicited by SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals has not yet been performed due to the challenge of directly probing human lymph nodes. Herein, through a fine-needle aspiration-based approach, we profiled the immune responses to SARS-CoV-2 mRNA vaccines in lymph nodes of healthy individuals and kidney transplant recipients (KTXs). We found that, unlike healthy subjects, KTXs presented deeply blunted SARS-CoV-2-specific GC B cell responses coupled with severely hindered T follicular helper cell, SARS-CoV-2 receptor binding domain-specific memory B cell, and neutralizing antibody responses. KTXs also displayed reduced SARS-CoV-2-specific CD4 and CD8 T cell frequencies. Broadly, these data indicate impaired GC-derived immunity in immunocompromised individuals and suggest a GC origin for certain humoral and memory B cell responses following mRNA vaccination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。